PROCARE

Procare Health is a pharmaceutical laboratory founded in 2012 focused on women's health and wellbeing. It is a company with headquarters in Spain and 100% private capital.

Procare Health has an innovation model with more than 30% of its budget allocated to R&D. Procare Health's products are mainly made with therapeutic principles of natural origin.

In three years, the company has 70 employees in Europe (Spain, France and Portugal). Its business model is based on the search for innovative therapeutic solutions, thanks to the formulation, development and clinical research of its own products in order to bring improvements in the field of women's health treatments.

During this time, Procare Health has been able to identify latent needs and formulate, research, develop, produce and launch a range of innovative products such as Palomacare® for the treatment of vaginal health in postmenopausal women and Papilocare®, the first treatment to prevent and treat cervical lesions caused by the Human Papilloma Virus (HPV).

Procare Health launches in Spain, Libicare®, the first 100% natural treatment to promote sexual desire in women affected by a sexual function disorder.